Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB2364

Introduced
7/18/23  

Caption

MAPS Act Mapping America's Pharmaceutical Supply Act

Impact

If enacted, SB2364 could significantly modify federal approaches to drug safety and availability. The creation of a centralized database could facilitate improved monitoring of the pharmaceutical supply chain, potentially reducing the risks of drug shortages during public health emergencies. Additionally, the act reinforces the federal government's role in overseeing pharmaceutical distribution, which may result in enhanced cooperation between government entities and private sector partners.

Summary

The 'Mapping America's Pharmaceutical Supply Act' or SB2364 aims to enhance the United States' oversight of its pharmaceutical supply chain. It mandates a comprehensive mapping of the entire supply chain, from production to distribution, to identify potential vulnerabilities and threats to national security. The bill proposes that the Secretary of Health and Human Services collaborate with other federal agencies, including Defense and Homeland Security, to develop a database listing essential medicines and their associated active ingredients, with the aim of ensuring a robust public health response in emergencies.

Contention

While many advocates praise SB2364 for its potential to improve public health infrastructure, there are concerns regarding the implications of data sharing between agencies. The bill ensures that confidential commercial information is protected and not publicly disclosed, raising questions about transparency and accountability. Critics may also argue about the adequacy of resources to implement such a comprehensive mapping and database system effectively, which could lead to gaps in addressing supply chain vulnerabilities.

Notable_points

One significant aspect of SB2364 is its focus on predictive analytics to anticipate potential drug shortages or threats. This proactive approach aims to enhance national preparedness for public health crises. However, the effectiveness of the proposed mapping and data analytics heavily depends on industry cooperation, which suggests that collaboration between the public and private sectors will be vital for the bill's success.

Companion Bills

No companion bills found.

Previously Filed As

US HB4191

MAPS Act Mapping America’s Pharmaceutical Supply Act

US SB1784

MAPS Act Mapping America's Pharmaceutical Supply Act

US HB6992

MAPS Act Mapping America’s Pharmaceutical Supply Act

US SB2510

RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

US SB2454

Pharmaceutical Supply Chain Security Act

US SB1961

Pharmaceutical Supply Chain Risk Assessment Act of 2023

US HB4449

Pharmaceutical Security Production Act

US HB6802

RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

US SB3311

American Made Pharmaceuticals Act of 2023

US HB9321

American Made Pharmaceuticals Act of 2024

Similar Bills

CA SB493

District agricultural associations: secretary-managers: compensation.

LA HB528

Reforms the organizational structure for the Department of Transportation and Development including its duties, powers, and responsibilities of officers and employees (EN INCREASE SD EX See Note)

MO HB2798

Modifies the "Missouri Family Trust Company Act"

CA AB1044

Elections: Secretary of State.

AR SB63

To Amend Arkansas Law Concerning Reports By The Secretaries Of Cabinet-level Departments On The State Of Their Departments.

CA AB1206

Voter registration database: Electronic Registration Information Center.

CA SB297

Elections: initiatives and referenda: withdrawal.

CA AB2050

Voter registration database: Electronic Registration Information Center